Lanoxin

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

25 API Suppliers, 10 USDMF, 10 CEP/COS, 4 JDMF, 5 EU WC, 1 KDMF, 11 NDC API, 11 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

106 FDF Dossiers, 38 FDA Orange Book, 24 Europe, 15 Canada, 5 Australia, 11 South Africa, 13 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 0.0625MG, TABLET;ORAL - 0.125MG, TABLET;ORAL - 0.1875MG, TABLET;ORAL - 0.25MG, ELIXIR;ORAL - 0.05MG/ML, INJECTABLE;INJECTION - 0.1MG/ML, INJECTABLE;INJECTION - 0.25MG/ML

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 17 SPI Pharma, 1 DKSH, 1 Jai Radhe Sales, 12 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 2 Actylis, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 BASF, 6 DFE Pharma, 1 Finar, 4 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 28 Kerry, 14 Microlex e.U, 1 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 28 Roquette, 1 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

78 Fillers, Diluents & Binders, 37 Direct Compression, 19 Disintegrants & Superdisintegrants, 18 Granulation, 17 Co-Processed Excipients, 16 Taste Masking, 15 Chewable & Orodispersible Aids, 15 Thickeners and Stabilizers, 14 Lubricants & Glidants, 13 Film Formers & Plasticizers, 11 Parenteral, 9 Coating Systems & Additives, 7 Controlled & Modified Release, 5 Topical, 4 Emulsifying Agents, 2 API Stability Enhancers, 2 Solubilizers, 2 Rheology Modifiers, 1 Soft Gelatin